Target Name: SCP2D1
NCBI ID: G140856
Other Name(s): SCP2 sterol-binding domain-containing protein 1 | Sterol carrier protein 2-like protein | C20orf79 | sterol carrier protein 2-like protein | HSD22 | dJ1068E13.2 | SCP2 sterol binding domain containing 1 | DJ1068E13.2 | SCP2D_HUMAN

SCP2D1: A Potential Drug Target and Biomarker

SCP2D1, or sterol-binding domain-containing protein 1, is a protein that has been identified as a potential drug target and biomarker. The protein is characterized by its unique sterol-binding domain, which allows it to interact with and modulate the activity of other proteins. This unique property has led to a high degree of interest in the potential drug targeting and biomarker development.

Drug Target Potential

SCP2D1 has been identified as a potential drug target due to its unique ability to interact with and modulate the activity of other proteins. The sterol-binding domain of SCP2D1 has been shown to interact with various drug targets, including G protein-coupled receptors (GPCRs) and ion channels. This interaction has the potential to modulate the activity of these drug targets, leading to potential therapeutic benefits.

In addition to its potential as a drug target, SCP2D1 has also been identified as a potential biomarker. The protein can be used as a protein-based marker to diagnose and monitor various diseases, including cancer, cardiovascular disease, and neurodegenerative diseases. This marker has the potential to provide a more specific and sensitive diagnostic tool for these diseases, potentially leading to earlier and more effective treatments.

Biomarker Potential

SCP2D1 has been shown to be involved in a variety of physiological processes, including cell signaling, DNA replication, and metabolism. Its unique sterol-binding domain has been shown to interact with various proteins, including the protein SMAD4, which plays a role in regulating DNA replication and metabolism. This interaction suggests that SCP2D1 may be involved in the regulation of important cellular processes, and its potential biomarker properties make it an attractive target for diagnostic tools.

Conclusion

In conclusion, SCP2D1 is a protein with a unique sterol-binding domain that has the potential to be a drug target and biomarker. Its interaction with various drug targets and its involvement in important cellular processes make it an attractive target for therapeutic development and diagnostic tools. Further research is needed to fully understand the role of SCP2D1 in disease and to develop effective treatments.

Protein Name: SCP2 Sterol Binding Domain Containing 1

More Common Targets

SCP2D1-AS1 | SCPEP1 | SCRG1 | SCRIB | SCRN1 | SCRN2 | SCRN3 | SCRT1 | SCRT2 | SCT | SCTR | SCUBE1 | SCUBE2 | SCUBE3 | SCXA | SCYL1 | SCYL2 | SDAD1 | SDAD1-AS1 | SDAD1P1 | SDC1 | SDC2 | SDC3 | SDC4 | SDCBP | SDCBP2 | SDCBP2-AS1 | SDCBPP2 | SDCCAG8 | SDE2 | SDF2 | SDF2L1 | SDF4 | SDHA | SDHAF1 | SDHAF2 | SDHAF3 | SDHAF4 | SDHAP1 | SDHAP2 | SDHAP3 | SDHAP4 | SDHB | SDHC | SDHD | SDHDP1 | SDHDP2 | SDK1 | SDK1-AS1 | SDK2 | SDR16C5 | SDR16C6P | SDR39U1 | SDR42E1 | SDR42E2 | SDR9C7 | SDS | SDSL | SEBOX | SEC11A | SEC11B | SEC11C | SEC13 | SEC14L1 | SEC14L1P1 | SEC14L2 | SEC14L3 | SEC14L4 | SEC14L5 | SEC14L6 | SEC16A | SEC16B | SEC1P | SEC22A | SEC22B | SEC22C | SEC23A | SEC23B | SEC23IP | SEC24A | SEC24AP1 | SEC24B | SEC24B-AS1 | SEC24C | SEC24D | SEC31A | SEC31B | SEC61A1 | SEC61A2 | SEC61B | SEC61G | SEC62 | SEC63 | SEC63P2 | SECISBP2 | SECISBP2L | SECTM1 | Segment polarity protein dishevelled homolog | SEH1L | SEL1L